Virtu Financial’s Shuttle Pharmaceuticals SHPH Stock Holding History

Virtu Financial’s Portfolio SHPH Stock Details SHPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,238	Closed	-$8K	–	2179
2026 Q1	$8K	Buy	+1,238	New	+$16.8K	﹤0.01%	1475
2024 Q3	–	Sell	-6	Closed	-$5K	–	1838
2024 Q2	$5K	Buy	6 +1	+20%	+$849	﹤0.01%	1185
2024 Q1	$4K	Sell	5 -5	-50%	-$4.21K	﹤0.01%	1302
2023 Q4	$9K	Buy	+10	New	+$10.2K	﹤0.01%	1421
2023 Q1	–	Sell	-8	Closed	-$31K	–	2044
2022 Q4	$31K	Sell	8 -1	-11%	-$4.86K	﹤0.01%	1179
2022 Q3	$78K	Buy	+9	New	+$367K	0.01%	1132

Other funds holding SHPH

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

KFA

Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return

Virtu Financial's SHPH Position: Q2 2026 in Review

Virtu Financial sold out of Shuttle Pharmaceuticals (SHPH) in Q2 2026, closing a stake of 1,238 shares — an estimated $8K sold.

Virtu Financial first reported a position in SHPH in Q3 2022 and held it in 6 quarters. The position peaked at $78K in Q3 2022. 5 funds tracked by Wall St. Rank hold SHPH as of Q2 2026.

Virtu Financial reported no remaining Shuttle Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 1,238 Shuttle Pharmaceuticals shares in Q2 2026, an estimated $8K.
Virtu Financial first reported a position in Shuttle Pharmaceuticals in Q3 2022 and held it in 6 quarters.
Virtu Financial's Shuttle Pharmaceuticals position peaked at $78K in Q3 2022.
5 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.